GeneOne Life Science, Inc. Logo

GeneOne Life Science, Inc.

Biopharmaceutical R&D company specializing in nucleic acid-based biomedicines.

011000 | KO

Overview

Corporate Details

ISIN(s):
KR7011000007
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 여의대로 108 20층(여의도동, 파크원NH금융타워(타워2)), 서울특별시

Description

GeneOne Life Science, Inc. is a biopharmaceutical research and development company specializing in nucleic acid-based biomedicines. The company's core focus is on developing DNA and mRNA vaccines, particularly for emerging infectious diseases, leveraging its rapid development platforms. In therapeutics, GeneOne utilizes a proprietary DNA plasmid delivery technology to enable the expression of recombinant proteins and plasmid-encoded monoclonal antibodies (Plas-mAbs®). This non-viral vector approach is designed to offer a safer and more cost-effective alternative to traditional gene therapies and cell-line derived monoclonal antibody treatments for conditions such as cancers and autoimmune disorders. The company also develops immunomodulatory small molecule drugs. Through its subsidiary, GeneOne possesses cGMP-grade manufacturing capabilities for DNA plasmids, supporting its internal pipeline and contract manufacturing services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-08-20 00:00
최대주주등소유주식변동신고서
Korean HTML 34.7 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.9 MB
2025-08-14 00:00
[기재정정]사업보고서 (2024.12)
Korean HTML 2.3 MB
2025-08-12 00:00
임시주주총회결과
Korean HTML 29.1 KB
2025-08-12 00:00
대표이사(대표집행임원)변경(안내공시)
Korean HTML 5.8 KB
2025-08-08 00:00
소송등의판결ㆍ결정
Korean HTML 5.9 KB
2025-08-08 00:00
소송등의판결ㆍ결정
Korean HTML 5.7 KB
2025-08-08 00:00
소송등의판결ㆍ결정
Korean HTML 5.7 KB
2025-08-08 00:00
소송등의판결ㆍ결정
Korean HTML 5.7 KB
2025-08-07 00:00
소송등의판결ㆍ결정
Korean HTML 7.1 KB
2025-08-05 00:00
[기재정정]주주총회소집공고
Korean HTML 261.0 KB
2025-08-05 00:00
[기재정정]의결권대리행사권유참고서류
Korean HTML 101.0 KB
2025-07-31 00:00
소송등의제기ㆍ신청(경영권분쟁소송)
Korean HTML 5.2 KB
2025-07-31 00:00
소송등의제기ㆍ신청(경영권분쟁소송)
Korean HTML 5.6 KB
2025-07-28 00:00
주주총회소집공고
Korean HTML 255.7 KB

Automate Your Workflow. Get a real-time feed of all GeneOne Life Science, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GeneOne Life Science, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GeneOne Life Science, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.